Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study
LLDAS and REM were achievable targets in HDAS patients, and provided significant protection against adverse outcomes.
Authors
- Sean O’Neill (ORCID: https://orcid.org/0000-0002-6739-832X)
- Annie Law (ORCID: https://orcid.org/0000-0003-3301-0603)
- Chak Sing Lau (ORCID: https://orcid.org/0000-0001-6698-8355)
- Cherica Tee (ORCID: https://orcid.org/0000-0002-0766-0189)
- Masayoshi Harigai (ORCID: https://orcid.org/0000-0002-6418-2603)
- Mandana Nikpour (ORCID: https://orcid.org/0000-0002-6585-5611)
- Jun Kikuchi (ORCID: https://orcid.org/0000-0003-3231-8841)
- Sandra Navarra (ORCID: https://orcid.org/0000-0003-0094-8654)
- Shue‐Fen Luo (ORCID: https://orcid.org/0000-0001-6559-4434)
- Eric Francis Morand (ORCID: https://orcid.org/0000-0002-9507-3338)
- Zhanguo Li (ORCID: https://orcid.org/0000-0002-2590-6242)
- Nicola Tugnet
- Alberta Hoi (ORCID: https://orcid.org/0000-0002-9416-7383)
- Madelynn Chan (ORCID: https://orcid.org/0000-0002-8102-7664)
- Naoaki Ohkubo (ORCID: https://orcid.org/0000-0003-2265-4104)
- Vera Golder (ORCID: https://orcid.org/0000-0001-5691-4344)
- Yeong‐Jian Jan Wu (ORCID: https://orcid.org/0000-0002-5444-4729)
- Yasuhiro Katsumata (ORCID: https://orcid.org/0000-0003-1654-0119)
- Fiona Goldblatt (ORCID: https://orcid.org/0000-0001-7205-4807)
- Zhuoli Zhang (ORCID: https://orcid.org/0000-0001-7219-9141)
- Worawit Louthrenoo (ORCID: https://orcid.org/0000-0003-3105-6122)
- Jiacai Cho (ORCID: https://orcid.org/0000-0002-4477-3430)
- BMDB Basnayake
- Laniyati Hamijoyo (ORCID: https://orcid.org/0000-0002-1310-674X)
- Rangi Kandane‐Rathnayake (ORCID: https://orcid.org/0000-0001-5397-1482)
- Tsutomu Takeuchi (ORCID: https://orcid.org/0000-0003-1111-8218)
- Michael Tee (ORCID: https://orcid.org/0000-0003-0113-8290)
- Aisha Lateef (ORCID: https://orcid.org/0000-0002-0838-7495)
- S. Oon
- Sunil Kumar (ORCID: https://orcid.org/0000-0001-9905-4831)
- Yoshiya Tanaka
- Yi‐Hsing Chen (ORCID: https://orcid.org/0000-0002-8135-9554)
- Leonid Zamora
- Sargunan Sockalingam
- Sang-Cheol Bae
- Kristine Ng (ORCID: https://orcid.org/0009-0006-6225-2715)
Institutions
- University of Santo Tomas Hospital (PH)
- The University of Sydney (AU)
- University Malaya Medical Centre (MY)
- University of Occupational and Environmental Health Japan (JP)
- Peking University (CN)
- Keio University (JP)
- Singapore General Hospital (SG)
- Middlemore Hospital (NZ)
- Queen Mary Hospital (CN)
- Liverpool Hospital (AU)
- North Shore Hospital (NZ)
- Tan Tock Seng Hospital (SG)
- Teaching Hospital Kandy (LK)
- Flinders Medical Centre (AU)
- Chang Gung Memorial Hospital (TW)
- University of Malaya (MY)
- St Vincent's Hospital Melbourne (AU)
- Taichung Veterans General Hospital (TW)
- Institute of Rheumatology (CZ)
- Greenlane Clinical Centre (NZ)
- Institute for Rheumatic Diseases (Japan) (JP)
- Monash Health (AU)
- Peking University People's Hospital (CN)
- Peking University First Hospital (CN)
- Tokyo Women's Medical University (JP)
- Hanyang University Seoul Hospital (KR)
- Woodlands Health Campus (SG)
- National University Hospital (SG)
- Woodlands Hospital (GB)
- Center for Rheumatology (US)
- Woodlands Hospital (GB)
- Hanyang University (KR)
- Chiang Mai University (TH)
- Monash University (AU)
- University of the Philippines Manila (PH)
- Saitama Medical University (JP)
- University of Hong Kong (HK)
- Padjadjaran University (ID)
- Anyang University (KR)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1093/rheumatology/keae631
- Citations
- 6
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 2.82
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Biogen
- Celgene
- GlaxoSmithKline Japan
- Kissei
- Boehringer Ingelheim Japan
- National Research Foundation
- Daiichi-Sankyo
- National Research Foundation of Korea
- Eisai
- Astellas Pharma
- Astellas Foundation for Research on Metabolic Disorders
- Teijin Pharma
- Mitsubishi Tanabe Pharma Corporation
- Idorsia Pharmaceuticals
- EMD Serono
- Pfizer Japan
- Chugai Pharmaceutical
- Eli Lilly Japan
- UCB Pharma